Don't sorry us. Pity yourself. Let's have a talk, when TLD hits.
Why is the data SO good?
Why did the blinded blended interim 2018 data look so good?
Why is the data 3 years later BOUND to be better?
Why is the fat tail of long term survivors SO long?
Why do NWBO continuously rake up one patent after another?
Why have NWBO ramped up manufactoring capabilities and applied for MHRA application for Sawston, for which a certification comes during the next 2-3 weeks?
Why did NWBO buy Flaskworks to be able to make their vaccine themselves?
Why did Flaskworks receive a patent for scaling up production?
Why have NWBO attached TWO uplisting consultants experts, the last on in May, 7 months into the data lock period?
Why did Kristyn Powers agree to be hired and leave a good manager job in April, 6 months into the data lock period?
Why are Advent BioServices, who is residing at same address in Sawston as NWBO, hiring so many, not least cell specialists?
Why is DCVax-L used in combo trials at UCLA with MERCK Keytruda?
Why did Linda Liau publish a book about glioblastoma researched, that praised DCVax-L just two months ago?
Why are warrant holders by and large NOT exercising or selling?
Why did Linda Liau suggest patients freeze their tumors for potential future analysis and treatment?
Why did Kevin Duffy not receive stocks or options when hired at NWBO?
Why are NWBO Titanium Sponser, the only one, at ABTA conference?
Why will Dr. Marnix Bosch speak about the future of Brain Cancer Immunutherapy at 3rd Annual GBM Drug Development Summit in January?
If one believes the period since DL has been quiet, one is wrong.
News 
Market Data 
Discover 
